Agrivalle Partners Ginkgo Bioworks To Advance Its Biological Products

Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets

Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity, announced Thursday the acquisition of microbial innovation firm AgBiome, Inc.'s platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome's development pipeline.

RTTNews | 355天前

Imagindairy And Ginkgo Bioworks Partner To Develop Animal-Free Non-Whey Dairy Proteins

Israeli-based foodtech company Imagindairy and Ginkgo Bioworks (DNA) announced Tuesday a new partnership with the aim to deliver a global solution for animal-free non-whey dairy protein production in a highly cost-effective manner.

RTTNews | 371天前

Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges

Ahead of its presentation at the 42nd Annual J.P. Morgan Healthcare Conference later on Wednesday, Ginkgo Bioworks (DNA) said it expects to meet its previously disclosed new program and revenue guidance ranges in 2023, based on its preliminary unaudited estimates.

RTTNews | 447天前

NAMUH, Ginkgo Bioworks Ink Partnership To Develop Functional Oligosaccharides

Infant nutrition company NAMUH and Ginkgo Bioworks Holdings, Inc. (DNA) announced Wednesday a multi-product collaboration to develop functional oligosaccharides that are structurally identical to those found in human breast milk.

RTTNews | 804天前

Ginkgo Bioworks Acquires Biotechnology Company Circularis For Undisclosed Terms

Ginkgo Bioworks (DNA), the leading horizontal platform for cell programming, announced Tuesday the tuck-in acquisition of Circularis, a biotechnology company with a proprietary circular RNA and promoter screening platform.

RTTNews | 910天前

Ginkgo Bioworks To Acquire Zymergen In All-stock Deal

Cell programming firm Ginkgo Bioworks Holdings, Inc. (DNA) and biotechnology company Zymergen, Inc. (ZY) announced Monday they have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization.

RTTNews | 981天前

Australia Building Approval Data Due On Wednesday

Australia will on Wednesday release February figures for building approvals, highlighting a modest day for Asia-Pacific economic activity. Approvals are expected to slip 1.4 percent on month and climbing 6.3 percent in January.

RTTNews | 6小时16分钟前

U.S. Dollar Drops Ahead Of Trump's Tariffs

The U.S. dollar fell against its major counterparts in the New York session on Tuesday after weak economic data, while investors awaited more details on U.S. President Donald Trump's reciprocal tariff announcements set to be announced on Wednesday.

RTTNews | 10小时2分钟前

EURUSD	1.07929	GBPUSD	1.29147	AUDUSD	0.62839
USDJPY	149.851	USDCAD	1.43017	USDCHF	0.8837

Advertisement

Agrivalle Partners Ginkgo Bioworks To Advance Its Biological Products